Aspirin May Cut Breast Cancer Risk

Armen Hareyan's picture

Aspirin use is found to cut breast cancer risk by 20%.

Scientists from Guy's and St Thomas' NHS Foundation Trust examined data from 21 studies conducted during the past 27 years, involving about 37000 women.


Women taking nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and over-the-counter drugs (OTC), such as ibuprofen, had lower breast cancer risk. Even those already suffering from the disease had improved quality of life.

Millions of people worldwide are using these drugs as pain-killer. The ability of drugs to cut heart attacks and strokes is already proved, now the drugs are shown to cut breast cancer risk.

Professor Fentiman warned: "We are not advocating that women take these drugs routinely until the benefits and risks are clearer. Our review did not look at the potential side-effects and it would be essential to take them into account. More research is clearly needed."

The researchers are not yet sure about the dose and the type of NSAIDs that cuts breast cancer risk. More research needs to be done to explain the exact way drugs affect the disease and to measure side effects for the long-term use of drug.